RNAC Cartesian Therapeutics, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Cartesian Therapeutics (RNAC) Stock: Buy, Sell, or Hold?

$6.34
-0.54 (-7.85%) â–ŧ
5d: -6.49% 30d: +0.0% 90d: -28.28%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (82%)
Quality Score
42/100
Position
SLIGHTLY LOW
30-Day Fair Range
$6.31 – $6.96
Position: SLIGHTLY LOW
Forward P/E & Valuation
-1.8x
Next 12M consensus est.
Wall Street Target
$33.67
+389.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.11 / $7.90
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: RNAC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When RNAC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: RNAC is currently trading at $6.34, which is considered slightly low relative to its 30-day fair value range of $6.31 to $6.96.

Technical Outlook: Technically, RNAC is in a strong downtrend. Immediate support is located at $6.11, while resistance sits at $7.90. Short-term momentum is weak, with the stock down 7.8% recently.

Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $33.67 (+389.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $6.31 - $6.96
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.1%

Trading Range & Key Levels

30-Day Trading Range $6.31 - $6.96
Current vs Trading Range SLIGHTLY LOW
Expected Move (7 Days) Âą$1.03 (16.2%)
Support Level $6.11
Resistance Level $7.90
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (43/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-7.8%)
  • BULLISH: Trading 389.3% below Wall St target ($33.67)
  • WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -1.81
Wall Street Target $33.67 (+389.3%)
Revenue Growth (YoY) -92.9%
Earnings Growth (YoY) -8.0%
Share RNAC Analysis

Share this live RNAC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (RNAC)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 22, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate bullish sentiment towards $RNAC with one user suggesting buying opportunities. No recent news articles were available.
Key Retail Themes: Buy opportunity Positive outlook
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:55 PM ET
Data refreshes hourly during market hours. Next update: 3:55 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RNAC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 52 HOLD
SRRK
Scholar Rock Holding Corp
STRONG BUY
18 analysts
$70 52 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 50 HOLD
WVE
Wave Life Sciences Ltd
STRONG BUY
21 analysts
$17 37 SELL
ARWR
Arrowhead Pharmaceuticalâ€Ļ
STRONG BUY
15 analysts
$108 50 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive RNAC Research Pages
RNAC Technical Chart RNAC Price Prediction RNAC Intrinsic Value DCF RNAC Earnings Date Why is RNAC Moving Today? RNAC Investment Advisor RNAC Fair Price Analyzer RNAC Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals